For localized gastroesophageal cancer, you give chemoradiation before surgery, but then what happens? [1]

Journal of Clinical Oncology

Volumn 25, Issue 27, 2007, Pages 4315-4316

  Ajani, Jaffer A ^a   Correa, Arlene M ^a   Swisher, Stephen G ^a   Wu, Tsung Teh ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER CHEMOTHERAPY; CANCER GRADING; CANCER LOCALIZATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RESISTANCE; CANCER STAGING; COVARIANCE; DIAGNOSTIC ACCURACY; ESOPHAGUS CANCER; HUMAN; LETTER; LYMPH NODE METASTASIS; PATHOLOGIST; PREDICTION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; STOMACH CANCER; UNIVARIATE ANALYSIS; ADENOCARCINOMA; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; CANCER INVASION; ESOPHAGUS TUMOR; METHODOLOGY; MULTIMODALITY CANCER THERAPY; NOTE; PATHOLOGY; RADIOTHERAPY; STOMACH TUMOR;

ADENOCARCINOMA; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; HUMANS; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PATHOLOGY; RADIOTHERAPY; STOMACH NEOPLASMS;

EID: 34948868825     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.11.8026     Document Type: Letter

References (13)

1. Rizk NP, Venkatraman E, Bains MS, et al: American Joint Committee on cancer staging does not accurately predict survival in patients receiving multimodality therapy for esophageal adenocarcinoma. J Clin Oncol 10:507-512, 2007
2. Gibson M, Burtness B, Heath E, et al: Effect of neoadjuvant chemoradiotherapy on pathologic stage and survival in patients with locally advanced esophageal cancer. Proc Am Soc Clin Oncol 22:14S, 2004 (abstr 4032)
3. Chirieac LR, Swisher SG, Ajani JA, et al: Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation. Cancer 103:1347-1355, 2005
4. Rohatgi PR, Mansfield PF, Crane CH, et al: Surgical pathology stage by the American Joint Commission on cancer criteria predicts patient survival after preoperative chemoradiation for localized gastric carcinoma. Cancer 107:1475-1482, 2006
5. Wang KL, Yang Q, Cleary KR, et al: The significance of neuroendocrine differentiation in adenocarcinoma of the esophagus and esophagogastric junction after preoperative chemoradiation. Cancer 107:1467-1474, 2006
6. Gu Y, Swisher SG, Ajani JA, et al: The number of lymph nodes with metastasis predicts survival in patients with esophageal or esophagogastric junction adenocarcinoma who receive preoperative chmoradiation. Cancer 106:1017-1025, 2006
7. Malaisrie SC, Hofstetter WL, Correa AM, et al: Endoscopic ultrasonography-identified celiac adenopathy remains a poor prognostic factor despite preoperative chemoradiotherapy in esophageal adenocarcinoma. J Thorac Cardiovasc Surg 131:65-72, 2006
8. Agarwal B, Swisher S, Ajani J, et al: Endoscopic ultrasound after preoperative chemoradiation can help identify patients who benefit maximally after surgical esophageal resection. Am J Gastroenterol 99:1258-1266, 2004
9. Rohatgi PR, Swisher SG, Correa AM, et al: Failure patterns correlate with the proportion of residual carcinoma after preoperative chemoradiotherapy for carcinoma of the esophagus. Cancer 104:1349-1355, 2005
10. Swisher SG, Hofstetter W, Wu TT, et al: Proposed revision of the esophageal cancer staging system to accommodate pathologic response following preoperative chemoradiation. Ann Surg 241:810-817, 2005
11. Chiriaec LR, Swisher SG, Correa AM, et al: Signet-ring cell or mucinous histology after preoperative chemoradiation and survival in patients with esophageal or esophagogastric junction. Clin Cancer Res 11:2229-2236, 2005
12. Rohatgi P, Swisher SG, Correa AM, et al: Characterization of pathologic complete response after preoperative chemoradiotherapy in carcinoma of the esophagus and outcome after pathologic complete response. Cancer 104:2365-2372, 2005
13. Wu TT, Chiriaec LR, Abraham SC, et al: Excellent interobserver agreement on grading the extent of residual carcinoma after preoperative chemoradiation in esophageal and esophagogastric junction carcinoma: A reliable predictor of patient outcome. Am J Surg Pathol 31:58-64, 2007